[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336176-105":59,"doc-detail-336176-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mixed-neuroendocrine-non-neuroendocrine-neoplasms-in-gastroenteropancreatic-tract-minireviews","Mixed neuroendocrine non-neuroendocrine neoplasms in gastroenteropancreatic tract - MINIREVIEWS","","Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are heterogeneous malignant neoplasms arising in the gastroenteropancreatic tract, defined by a neuroendocrine (NE) and a non-NE component present in at least 30% of each tumour. Non-NE components may include glandular, squamous, mucinous, or sarcomatoid phenotypes, with either or both components ranging from low- to high-grade malignancy. Changing nomenclature and limited clinical trial data complicate management. This review clarifies MiNEN definitions and evaluates diagnostic and treatment evidence by location and extension, aiming for consensus and stable classification to support clinical trial design despite low incidence.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mixed-neuroendocrine-non-neuroendocrine-neoplasms-in-gastroenteropancreatic-tract-minireviews/336176/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mixed-neuroendocrine-non-neuroendocrine-neoplasms-in-gastroenteropancreatic-tract-minireviews/336176.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What defines a mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)?","Question",{"text":112,"@type":113},"MiNENs are malignancies in the gastroenteropancreatic tract containing both a neuroendocrine (NE) component and a non-NE component, each present in at least 30% of the tumour.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What histological types can the non-NE component include?",{"text":117,"@type":113},"The non-NE component can include glandular, squamous, mucinous, and sarcomatoid phenotypes. One or both components may be low- or high-grade malignant.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is management of MiNENs considered difficult?",{"text":121,"@type":113},"Management is difficult due to confusion from recent nomenclature changes and the lack of specific, high-quality clinical trials, leaving few validated protocols or guidelines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336176,1790149193,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","| W | J | G | O | World Journal of\u003Cbr>Gastrointestinal Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastrointest Oncol 2024 April 15; 16(4): 1166-1179  \nDOI: 10.4251/wjgo.v16.i4.1166 ISSN 1948-5204 (online)  \nMINIREVIEWS  \nMixed neuroendocrine non-neuroendocrine neoplasms ingastroenteropancreatic tract  \nSebastián Díaz-López, Jerónimo Jiménez-Castro, Carlos Enrique Robles-Barraza, Carlos Ayala-de Miguel, Manuel Chaves-Conde  \nSpecialty type: Oncology  \nProvenance and peer review:  \nInvited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s scientific quality classification  \nGrade A (Excellent): 0  \nGrade B (Very good): B  \nGrade C (Good): C  \nGrade D (Fair): 0  \nGrade E (Poor): 0  \nP-Reviewer: Cigrovski Berkovic M, Croatia; Sun D, China  \nReceived: December 6, 2023  \nPeer-review started: December 6, 2023  \nFirst decision: January 6, 2024  \nRevised: January 17, 2024  \nAccepted: February 18, 2024  \nArticle in press: February 18, 2024  \nPublished online: April 15, 2024  \nSebastián Díaz-López, Jerónimo Jiménez-Castro, Carlos Enrique Robles-Barraza, Carlos Ayala-de Miguel, Manuel Chaves-Conde, Medical Oncology Department, Hospital Universitario Valme, Seville 41014, Andalucía, Spain  \nCorresponding author: Jerónimo Jiménez-Castro, MD, Staff Physician, Medical Oncology Department, Hospital Universitario Valme, Ctra. de Cádiz Km. 548.9, C.P. 41014, Seville, Andalucía, [Spain.](Spain. jerojc@gmail.com)[ jerojc@gmail.com](Spain. jerojc@gmail.com)  \nAbstract  \nMixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are a heterogeneous group of malignant neoplasms that can settle in the gastroenteropancreatic tract. They are composed of a neuroendocrine (NE) and a non-NE component in at least 30% of each tumour. The non-NE component can include different histological combinations of glandular, squamous, mucinous and sarcomatoid phenotypes, and one or both of the components can be low-or high grade malignant. Recent changes in the nomenclature of these neoplasms might lead to great deal of confusion, and the lack of specific clinical trials is the main reason why their management is difficult. The review aims to clarify the definition of MiNEN and analyze available evidence about their diagnosis and treatment options according to their location and extension through careful analysis of the available data. It would be important to reach a general consensus on their diagnosis in order to construct a classification that remains stable over time and facilitates the design of clinical trials that, due to their low incidence, will require long recruitment periods.  \nKey Words: Mixed neuroendocrine non-neuroendocrine neoplasms; Mixed adenoneuroendocrine carcinomas; Mixed tumours; Gastroenteropancreatic; Treatment; Etiology; Diagnosis  \n©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.  \n WJGO  [https://www.wjgnet.com](https://www.wjgnet.com) 1166 April 15, 2024  Volume 16  Issue 4   \nDíaz-López S et al. MiNEN in GEP tract  \nCore Tip: In this review we try to clarify definition of mixed neuroendocrine (NE) non-NE tumours that have been changed along past years and analyze available evidence about their diagnosis and treatment options according to their location and extension. We have to bear in mind that we do not have validated protocols or clinical guidelines on the management of this group of diseases, although most authors propose treating mixed NE non-NE neoplasm with the high-grade NE component as treatment target. In any case, the lack of high-quality scientific evidence, based on randomised clinical trials, makes it essential to deepen our knowledge of this group of neoplasms.  \nCitation: Díaz-López S, Jiménez-Castro J, Robles-Barraza CE, Ayala-de Miguel C, Chaves-Conde M. Mixed neuroendocrine nonneuroendocrine neoplasms in gastroenteropancreatic tract. World J Gastroin","cbCaivaC3PwWr3ER","https://ap.wps.com/l/cbCaivaC3PwWr3ER","pdf",3957274,15,"English","# Abstract\n# Core Tip\n# Introduction\n## Historical evolution and terminology (Cordier to WHO classifications)\n# Diagnosis and treatment evidence (by location and extension)","[{\"question\":\"What defines a mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)?\",\"answer\":\"MiNENs are malignancies in the gastroenteropancreatic tract containing both a neuroendocrine (NE) component and a non-NE component, each present in at least 30% of the tumour.\"},{\"question\":\"What histological types can the non-NE component include?\",\"answer\":\"The non-NE component can include glandular, squamous, mucinous, and sarcomatoid phenotypes. One or both components may be low- or high-grade malignant.\"},{\"question\":\"Why is management of MiNENs considered difficult?\",\"answer\":\"Management is difficult due to confusion from recent nomenclature changes and the lack of specific, high-quality clinical trials, leaving few validated protocols or guidelines.\"}]","Mixed neuroendocrine non-neuroendocrine neoplasms in gastroenteropancreatic tract - MINIREVIEWS | PDF",1790013982,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b26ff09e0986b644172570e48664625.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/050eb24dce4d617bfa8ceacab35ba426.webp",982,1389,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b30dbd273c6c9aef627b980ec1cf78b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b140f7c6dcc0527a7d4f46919b447c7a.webp",980,1386]